Xspray-logo-white
  • Home
  • About us
    • Business model
    • Our history – a timeline
    • Board of Directors & Board committees
    • Management
  • Technology
  • Pipeline
  • Media
  • Contact
  • Investors
  • en en
    • sv sv
  • Investors
    • Share information
      • Ownership structure
    • Financial calendar & Events
    • Financial reports
      • ESEF report
    • Prospectus
    • Press releases
    • Corporate governance
      • Corporate Structure
      • General meetings
      • Corporate Governance Reports
      • Nomination committee
      • Board of Directors & Board committees
      • Management
      • Accounting principles
      • Internal control & Risk management
      • Auditor
      • Articles of association
      • Remuneration

Financial reports

2025

Interim Report Q1 2025

2024

Interim Report Q1 2024
Interim Report Q2 2024
Interim Report Q3 2024
Year End Report 2024
Annual Report 2024

2023

Interim Report Q1 2023
Interim Report Q2 2023
Interim Report Q3 2023
Year End Report 2023
Annual Report 2023

2022

Interim Report Q1 2022
Interim Report Q2 2022
Interim Report Q3 2022
Year End Report 2022
Annual Report 2022

2021

Interim Report Q1 2021
Interim Report Q2 2021
Interim Report Q3 2021
Year End Report 2021
Annual Report 2021

2020

Interim Report Q1 2020
Interim Report Q2 2020
Interim Report Q3 2020
Year End Report 2020
Annual Report 2020

2019

Interim Report Q1 2019
Interim Report Q2 2019
Interim Report Q3 2019
Year End Report 2019
Annual Report 2019

2018

Year End Report 2018
Annual Report 2018

2017

Xspray-logo-white

Xspray Pharma AB Scheeles väg 2 171 65 Solna

+46 (0)8 730 37 00 info@xspraypharma.com

We use cookie to give you the best experience of our site. If you continue to use this website we will assume you agree. Read more about our Privacy policy.I agree